OPKO HealthOPK -0.66%56 Days Inventory is 75.74 as of Mar. 2026, which is 112% above its 10-year median of 35.69. GuruFocus rates OPK with a GF Score™ of 56/100 and a GF Value™ of $1.06 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 176 Medical Diagnostics & Research companies, OPKO Health ranks better than 52.84% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). OPKO Health's Average Total Inventories for the
three
months ended in Mar. 2026 was $65.1 Mil. OPKO Health's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $78.4 Mil.
Hence, OPKO Health's Days Inventory for the
three
months ended in Mar. 2026 was 75.74.
The historical rank and industry rank for OPKO Health's Days Inventory or its related term are showing as below:
OPK'
s Days Inventory Range Over the Past 10 Years
Min: 25.94 Med: 35.69 Max: 63.87
Current: 63.87
During the past 13 years, OPKO Health's highest Days Inventory was 63.87. The lowest was 25.94. And the median was 35.69.
OPK's Days Inventory is ranked better than 52.84% of 176
companies
in the Medical Diagnostics & Research industry
Industry Median: 68.88
vs OPK: 63.87
OPKO Health's Days Inventory
increased
from Mar. 2025 (51.35) to Mar. 2026 (75.74).
It might indicate that OPKO Health's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
OPKO Health's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.20.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
OPKO Health's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.52.
OPKO Health (NAS:OPK) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
OPKO Health's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
OPKO Health's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
OPKO Health Days Inventory Related Terms
OPKO Health Days Inventory Historical Data
* Premium members only.
The historical data trend for OPKO Health's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OPK vs PSNL, CDNA, CSTL: Days Inventory Comparison
For the Diagnostics & Research subindustry, OPKO Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OPKO Health Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Days Inventory distribution charts can be found below:
* The bar in red indicates where OPKO Health's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OPKO Health (OPK) has a Days Inventory of 75.74 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on OPKO Health and its competitors. This is 112% above median its historical median of 35.69. Over the past decade, OPKO Health's Days Inventory has ranged from 25.94 to 63.87. According to the industry distribution chart, OPKO Health ranks #83 out of 176 companies in the Medical Diagnostics & Research industry, placing it in the top 47.2%.
Is OPKO Health's Days Inventory too high?
OPKO Health's current Days Inventory of 75.74 is 112% above median its 10-year median of 35.69. Over the past 10 years, this metric has ranged from a low of 25.94 to a high of 63.87. The Medical Diagnostics & Research industry median Days Inventory is 68.88. OPKO Health's value of 75.74 is 10% above this industry median. Based on the distribution chart, OPKO Health ranks #83 out of 176 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, OPKO Health has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's Days Inventory compare to PSNL and CDNA?
According to the Medical Diagnostics & Research industry distribution chart, OPKO Health ranks #83 out of 176 companies for Days Inventory. This puts OPKO Health in the upper half of its industry. The industry median Days Inventory is 68.88. OPKO Health's value of 75.74 is 10% above this benchmark. Historically, OPKO Health's own Days Inventory has ranged from 25.94 to 63.87 over the past decade. While the company's 10-year median is 35.69 vs. the industry median of 68.88, OPKO Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.88, based on 176 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OPKO Health's current Days Inventory of 75.74 is 10% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on OPKO Health and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OPKO Health's current Days Inventory is 75.74, which is 112% above median its own 10-year median of 35.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (OPK) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.06, compared to a current price of $1.50 — trading 41.5% above its estimated fair value. The current Days Inventory is 75.74, which is 112% above median its 10-year median of 35.69 and 10% above the Medical Diagnostics & Research industry median of 68.88. OPKO Health's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For OPKO Health (OPK), the current Days Inventory is 75.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OPKO Health (OPK) Overvalued in 2026?
Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued.
The current stock price of $1.50 is trading 41.5% above its estimated GF Value™ of $1.06.
GuruFocus considers OPKO Health to be Significantly Overvalued.
Key valuation signals for OPK:
Days Inventory: 75.74 (112% above median its 10-year median of 35.69)
GF Value™: $1.06 vs. price of $1.50 (41.5% above fair value)
Industry Position: 10% above the Medical Diagnostics & Research median (#83 of 176)
No single metric tells the full story. See the OPK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
56GF Score
Get the complete analysis for OPK
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPK has been successfully added to your 
